Aifred Health

Aifred Health is a Montreal-based digital healthcare company that specializes in an AI-driven clinical decision support system (CDSS) designed to personalize treatment for patients

with moderate to severe depression. Founded in 2017, the company has developed a software solution that uses deep-learning algorithms to analyze patient data, predicting individual remission probabilities for first-line psychiatric treatments. This innovative approach helps clinicians make informed decisions tailored to each patient's needs. The company has received Health Canada approval for its medical device license and is recognized as an IBM Watson AI XPRIZE finalist, ranking highly in North America and globally for its depression treatment model. Aifred Health operates a business-to-business model, serving primary care physicians, psychiatrists, clinical research organizations, hospitals, and physician clinics. The company aims to expand its AI platform to cover all mental health conditions and is preparing for entry into the US market following its FDA application.